Pre-exposure Prophylaxis of SARS-CoV-2 Infection (COVID-19) by Monoclonal Antibodies With Early Access Authorization in Immunocompromised Patients. A Prospective Cohort.

Name: Pre-exposure Prophylaxis of SARS-CoV-2 Infection (COVID-19) by Monoclonal Antibodies With Early Access Authorization in Immunocompromised Patients. A Prospective Cohort.
Published: 2022
License: Public Domain

ANRS, Emerging Infectious Diseases · 2022

ClinicalTrials.gov · Datasets · License: Public Domain · 2022

Open Source ↗

exposureprophylaxis

covid-19, immunocompromised host, post-exposure prophylaxis, antibodies monoclonal, neutralizing antibodies, observational

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Pre-exposure Prophylaxis of SARS-CoV-2 Infection (COVID-19) by Monoclonal Antibodies With Early Access Authorization in Immunocompromised Patients. A Prospective Cohort.

Related documents